BG103779A - Crystallohydrate sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ilidenmethyl)-1h-i ndole-2-carboxylic acid - Google Patents

Crystallohydrate sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ilidenmethyl)-1h-i ndole-2-carboxylic acid

Info

Publication number
BG103779A
BG103779A BG103779A BG10377999A BG103779A BG 103779 A BG103779 A BG 103779A BG 103779 A BG103779 A BG 103779A BG 10377999 A BG10377999 A BG 10377999A BG 103779 A BG103779 A BG 103779A
Authority
BG
Bulgaria
Prior art keywords
sodium salt
ilidenmethyl
crystallohydrate
ndole
phenylpyrrolidine
Prior art date
Application number
BG103779A
Other languages
Bulgarian (bg)
English (en)
Inventor
Zadeo Cimarosti
Paolo Maragni
Original Assignee
Glaxo Wellcome S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome S.P.A. filed Critical Glaxo Wellcome S.P.A.
Publication of BG103779A publication Critical patent/BG103779A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG103779A 1997-03-05 1999-10-04 Crystallohydrate sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ilidenmethyl)-1h-i ndole-2-carboxylic acid BG103779A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9704498.6A GB9704498D0 (en) 1997-03-05 1997-03-05 Chemical compound
PCT/EP1998/001146 WO1998039327A1 (en) 1997-03-05 1998-03-03 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid

Publications (1)

Publication Number Publication Date
BG103779A true BG103779A (en) 2000-06-30

Family

ID=10808697

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103779A BG103779A (en) 1997-03-05 1999-10-04 Crystallohydrate sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ilidenmethyl)-1h-i ndole-2-carboxylic acid

Country Status (29)

Country Link
EP (1) EP0966463A1 (id)
JP (1) JP2001513796A (id)
KR (1) KR20000075907A (id)
CN (1) CN1249750A (id)
AP (1) AP9901637A0 (id)
AR (1) AR011178A1 (id)
AU (1) AU6825198A (id)
BG (1) BG103779A (id)
BR (1) BR9808305A (id)
CA (1) CA2282851A1 (id)
CO (1) CO4940415A1 (id)
EA (1) EA199900710A1 (id)
EE (1) EE9900387A (id)
GB (1) GB9704498D0 (id)
HR (1) HRP980114A2 (id)
HU (1) HUP0002109A2 (id)
ID (1) ID24207A (id)
IL (1) IL131489A0 (id)
IS (1) IS5166A (id)
NO (1) NO994303L (id)
NZ (1) NZ337315A (id)
OA (1) OA11154A (id)
PE (1) PE51399A1 (id)
PL (1) PL335652A1 (id)
SK (1) SK119699A3 (id)
TR (1) TR199902117T2 (id)
WO (1) WO1998039327A1 (id)
YU (1) YU43499A (id)
ZA (1) ZA981791B (id)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704499D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
CN110996948A (zh) 2017-06-12 2020-04-10 格莱泰施有限责任公司 用nmda拮抗剂和d2/5ht2a或选择性5ht2a拮抗剂治疗抑郁症

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
PL335652A1 (en) 2000-05-08
TR199902117T2 (xx) 2000-03-21
IL131489A0 (en) 2001-01-28
PE51399A1 (es) 1999-06-07
AU6825198A (en) 1998-09-22
SK119699A3 (en) 2000-05-16
KR20000075907A (ko) 2000-12-26
OA11154A (en) 2003-04-16
NO994303D0 (no) 1999-09-03
BR9808305A (pt) 2000-05-16
CO4940415A1 (es) 2000-07-24
IS5166A (is) 1999-08-27
EE9900387A (et) 2000-04-17
ZA981791B (en) 1999-09-03
CA2282851A1 (en) 1998-09-11
NZ337315A (en) 2001-02-23
WO1998039327A1 (en) 1998-09-11
NO994303L (no) 1999-11-03
GB9704498D0 (en) 1997-04-23
AR011178A1 (es) 2000-08-02
EA199900710A1 (ru) 2000-04-24
HUP0002109A2 (hu) 2001-04-28
JP2001513796A (ja) 2001-09-04
HRP980114A2 (en) 1998-12-31
ID24207A (id) 2000-07-13
CN1249750A (zh) 2000-04-05
YU43499A (sh) 2000-12-28
EP0966463A1 (en) 1999-12-29
AP9901637A0 (en) 1999-09-30

Similar Documents

Publication Publication Date Title
BG101250A (en) Salts of an anti-migraine indole derivative
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
AU6576898A (en) Fungicidal trifluorophenyl-triazolopyrimidines
IL112495A0 (en) Phenylacetic acid derivatives, their preparation and compositions containing them
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
BG101110A (en) Substituted pyrimidine compounds and their application
CA2260337A1 (en) Therapeutic agents
TR199700844T1 (xx) Pirazolil-Benzoil T�revleri.
AP2002002637A0 (en) Novel piperazine
IL132238A0 (en) Fungicidal trifluromethylalkylamino - triazolopyrimidines
HN1998000036A (es) Compuesto de pirazina
BR0014651A (pt) Inibidores de adesão de célula mediada por "alfa" l beta2
MX9605741A (es) Clorhidrato cristalino del (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzisotiazol-2-il)-butil ]-aminometil} cromano.
BG101893A (en) Nodulosporic acid derivatives
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
MX9709398A (es) N-aril-1,2,4-triazolin-5-onas.
IL111966A0 (en) 4-Benzoylisoxazole derivatives, their preparation and herbicidal compositions containing them
BG103779A (en) Crystallohydrate sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ilidenmethyl)-1h-i ndole-2-carboxylic acid
EP1026162A4 (en) ANTI-RHUMATISMAL AGENT
BG106016A (en) Resorcinol derivatives
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
NZ333854A (en) Intermediates for the preparation of 2-imidazoline-5-ones
MX9701764A (es) Derivados de imidoacidos.
IL138638A0 (en) Processes for preparing intermediates